No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Sjogren's Syndrome is a chronic autoimmune disorder that affects the body's moisture-producing glands, leading to dry eyes and dry mouth. It is classified as an allergy and immunology disorder, and is the second most common autoimmune disorder after rheumatoid arthritis. Symptoms of Sjogren's Syndrome include dry eyes, dry mouth, fatigue, joint pain, and rashes. Treatment options include medications, lifestyle changes, and surgery.
The Sjogren's Syndrome market is composed of a variety of companies that provide treatments and services for the disorder. These include pharmaceutical companies that develop and market medications, medical device companies that produce products to treat dry eyes and dry mouth, and biotechnology companies that develop treatments for the disorder. Additionally, there are companies that provide services such as patient education, support groups, and clinical trials.
Companies in the Sjogren's Syndrome market include AbbVie, AstraZeneca, Biogen, Bristol-Myers Squibb, GlaxoSmithKline, Novartis, Pfizer, and Regeneron. Show Less Read more
